Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China
NCT06717178
Summary
The goal of this observational study is to learn about the impact of chemotherapy-related toxicity on older cancer patients in China. The main question it aims to answer is: Does the Cancer and Aging Research Group (CARG) chemotherapy toxicity risk score predict chemotherapy-related toxicity in Chinese cancer patients over age 70? Participants over age 70 on systemic chemotherapy will answer questions listed in the CARG chemotherapy toxicity risk tool.
Eligibility
Inclusion Criteria: * Age≥ 70 years old * Confirmed diagnosis of solid tumor (any stage) * ECOG-PS score 0-2 points * Admission to the hospital for a new chemotherapy regimen (initial or change) * Patients need to have the ability to read and write, or communicate in Chinese * The patient must have the ability to give informed consent. Exclusion Criteria: * Patients who are on immunotherapy and/or targeted therapy only * Patients with hematologic malignancy * Patients with severe infections (sepsis, severe respiratory tract infections, severe urinary tract infections, severe abdominal infections, etc.). * Patients with severe heart, liver, and kidney dysfunction or failure
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06717178